VINCERX PHARMA INC

Historical 13F Holders

Symbol
VINC
CUSIP
92731L304
All holders as of
Q2 2025
Type
Equity
Class
COM NEW
Reported Value, Excluding Options
Total Filings

13D/G Filers

Investors who own more than 5% of a class must file a Schedule 13D or 13G. Every filing for 92731L304 since 12/18/2024, newest first.

Filer % of Class Filed
Armistice Capital, LLC 13G/A Amendment 2
4.99% 5/15/2025
Event 3/31/2025
Armistice Capital, LLC 13G/A Amendment 1
10.0% 2/14/2025
Event 12/31/2024
Prosight Management, LP 13G/A Amendment 2
4.99% 2/12/2025
Event 12/31/2024

13F Holders by Quarter

Period Filings Shares, Excl. Options Value, Excl. Options
2025 Q2 1 50.0 $2.00
2025 Q1 15 221 k $117 k
2024 Q4 1 1.00 k $263.00